How Long Will the Economic Downturn Affect the Dental Biomaterials Market?

Despite minimal growth in 2009, the US dental biomaterials market will rebound
to reach upwards of $230 million by 2013, according to Millennium Research
Group

WALTHAM, Mass., March 24 /PRNewswire/ -- According to Millennium Research
Group's (MRG's) US Markets for Dental Biomaterials 2009 report, although
dental biomaterials are being used in a growing proportion of dental implant
procedures, the market for these products will be dampened by the global
financial crisis in the coming years as many patients postpone dental implant
procedures or choose less expensive alternatives such as crowns.

Nonetheless, the US market for dental biomaterials continued to grow in 2008
due to several significant market events: BIOMET 3i's Endobon and NovaBone's
NovaBone were launched in the US in the second quarter of 2008; the US import
ban on Straumann's Emdogain and BoneCeramic we lifted in August, making these
products available toward the end of the year; Curasan's dental business was
purchased by RIEMSER Arzneimittel, a German pharmaceutical company;
Regeneration Technologies and Tutogen Medical merged and now operate under the
new name RTI Biologics; and Lifecore Biomedical's dental division merged with
Keystone Dental following Lifecore Biomedical's acquisition by Warburg Pincus.

"These events supported market expansion in 2008 and highlight the revenue
potential in the dental biomaterial space," says Kevin Flewwelling, Manager of
the Orthopedics division at MRG. "Although 2009 will be a challenging year
for dental biomaterial sales, market growth will continue through 2013."

MRG's US Markets for Dental Biomaterials 2009 report provides coverage of key
industry competitors, including ACE Surgical Supply, BioHorizons, BIOMET 3i,
DENTSPLY Friadent, Geistlich, GORE Medical Products, Keystone Dental, LifeNet
Health, NovaBone Products, Osteogenics Biomedical, Osteohealth, RIEMSER
Arzneimittel (incl. Curasan), RTI Biologics, Straumann, and many more.

About Millennium Research GroupMillennium Research Group (www.MRG.net), a
Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global
authority on medical technology market intelligence and the leading provider
of strategic information to the health care sector. The company provides
specialized industry expertise through published reports, ongoing
Marketrack(TM) projects, and customized solutions.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers
best-in-class, high-value information, and insights on important sectors of
the health care industry. Clients rely on this analysis and data to make
informed decisions. Please visit Decision Resources, Inc. at
www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be
trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn
Millennium Research Group
416-364-7776 x101
akrohn@mrg.net

Elizabeth Marshall
Decision Resources Inc.
781-296-2563
emarshall@dresources.com

SOURCE Millennium Research Group

Amy Krohn of Millennium Research Group, +1-416-364-7776, ext. 101,
akrohn@mrg.net, or Elizabeth Marshall of Decision Resources Inc.,
+1-781-296-2563, emarshall@dresources.com